Shareholder Alert: Ademi LLP investigates whether Inari Medical, Inc. is obtaining a Fair Price for its Public Shareholders
Inari Medical, Inc. (NARI)
Company Research
Source: Business Wire
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Inari (NASDAQ: NARI) for possible breaches of fiduciary duty and other violations of law in its transaction with the Stryker.Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.In the transaction, Inari stockholders will receive $80 per share, representing a total fully diluted equity value of approximately $4.9 billion. Inari insiders will receive substantial benefits as part of change of control arrangements.The transaction agreement unreasonably limits competing transactions for Inari by imposing a significant penalty if Inari accepts a competing bid. We are investigating the conduct of Inari’ board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights thro
Show less
Read more
Impact Snapshot
Event Time:
NARI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NARI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NARI alerts
High impacting Inari Medical, Inc. news events
Weekly update
A roundup of the hottest topics
NARI
News
- INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARIBusiness Wire
- Inari Medical, Inc. (NASDAQ: NARI) had its "equal weight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $80.00 price target on the stock, up previously from $65.00.MarketBeat
- $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inari Medical, Inc. - NARIPR Newswire
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GETY, SSTK, NARI, CLBR on Behalf of ShareholdersPR Newswire
- Inari Medical, Inc. (NASDAQ: NARI) had its "market perform" rating re-affirmed by analysts at William Blair.MarketBeat
NARI
Earnings
- 10/28/24 - Miss
NARI
Sec Filings
- 1/7/25 - Form SC14D9C
- 1/7/25 - Form SC
- 1/7/25 - Form SC
- NARI's page on the SEC website